A Randomized Phase II Study of S-1 Adjuvant Chemotherapy With or Without Hochu-ekki-to, a Japanese Herbal Medicine, for Stage II/III Gastric Cancer: The KUGC07 (SHOT) Trial
Objectives: A multicenter randomized phase II study was conducted to evaluate the effects of Hochu-ekki-to (TJ-41) for reducing adverse reactions and increasing compliance with S-1 adjuvant therapy for advanced gastric cancer.Methods: The eligibility criteria were pathological stage II/III after R0...
Main Authors: | Hiroshi Okabe, Yousuke Kinjo, Kazutaka Obama, Hisahiro Hosogi, Hiroaki Hata, Yoshito Asao, Hideki Harada, Dai Manaka, Atsushi Itami, Satoshi Teramukai, Yoshiharu Sakai |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-04-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2019.00294/full |
Similar Items
-
Hochu-ekki-to Treatment Improves Reproductive and Immune Modulation in the Stress-Induced Rat Model of Polycystic Ovarian Syndrome
by: Eunkuk Park, et al.
Published: (2017-06-01) -
Hochu-Ekki-To Improves Motor Function in an Amyotrophic Lateral Sclerosis Animal Model
by: Mudan Cai, et al.
Published: (2019-11-01) -
Traditional Japanese Herbal Medicine Hochu-Ekki-to Promotes Pneumococcal Colonization Clearance via Macrophage Activation and Interleukin 17A Production in Mice
by: Sho Nakakubo, et al.
Published: (2020-10-01) -
Combination therapy with antioxidants improves total motile sperm counts: A Preliminary Study
by: Kazutaka Terai, et al.
Published: (2020-01-01) -
The translational aspect of complementary and alternative medicine for cancer with particular emphasis on Kampo
by: Marie eAmitani, et al.
Published: (2015-08-01)